Fosfomycin versus ciprofloxacin for febrile neutropenia prophylaxis in high-risk haematological patients (FOVOCIP): a phase 3, open-label, multicentre, randomised, non-inferiority trial - ScienceDirect
#Fosfomycin did not demonstrate non-inferiority to #ciprofloxacin in the prevention of #febrileneutropenia in high-risk #haematologicalpatients. The higher incidence of Gram-negative bacteraemia discourages its use
https://www.sciencedirect.com/science/article/pii/S2666776226001109


